Ladabaum U,Dominitz JA,Kahi C,Schoen RE .2019 .Strategies for colorectal cancer screening. Gastroenterology, 06(2) : 418-32.
Kong Y,Hong L,Xu X .2020 .Potentially resectable mCRC-treated with cetuximab combined with chemotherapy. J Coll Physicians Surg Pak, 11(11) : 1206-12.
Wang P,Lv C,Zhang T,Liu J,Yang J,Guan F .2017 .FOXQ1 regulates senescence-associated in ammationvia activation of SIRT1 expression. Cell Death Dis, 340(7) : .
Li Y,Zhang Y,Yao Z,Li S,Yin Z,Xu M. .2016 .Forkhead box Q1: A key player in the pathogenesis of tumours (review). Int J Oncol, 3517(1) : 51-8.
Wu C,Zheng C,Chen S,He Z,Hua H,Sun C .2023 .FOXQ1 promotes pancreatic cancer cell proliferation, tumour stemness, invasion and metastasis through regulation of LDHAmediated aerobic glycolysis. Cell Death Dis, 10(10) : 699.
Zhang H,Meng F,Liu G,Zhang B,Zhu J,Wu F .2011 .Forkhead transcription factor FOXQ1 promotes epithelial-mesenchymal transition and breast cancer metastasis. Cancer Res, 10(4) : 0008-5472.
Kaneda H,Arao T,Tanaka K,Tamura D,Aomatsu K,Kudo K .2010 .FOXQ1 is overexpressed in colorectal cancer and enhances tumourigenicity and tumour growth. Cancer Res, 09(5) : 0008-5472.
Yang M,Liu Q,Dai M,Peng R,Li X,Zuo W .2022 .FOXQ1-mediated SIRT1 upregulation enhances stemness and radioresistance of colorectal cancer cells and restores intestinal microbiota function by promoting beta-catenin nuclear translocation. J Exp Clin Cancer Res, 10(1) : 70.
Mitchell AV,Wu L,Block CJ,Zhang M,Hackett J,Craig DB .2022 .FOXQ1 recruits the MLL complex to activate transcription of EMT and promote breast cancer metastasis. Nat Commun, 10(1) : 6548.
Hong X,Liu N,Liang Y,He Q,Yang X,Lei Y .2020 .Circular RNA CRIM1 functions as a ceRNA to promote nasopharyngeal carcinoma metastasis and docetaxel chemoresistance through upregulating FOXQ1. Mol Cancer, 10(1) : 33.
Fan J,Bertino JR .1999 .Modulation of cisplatinum cytotoxicity by p53: E ect of p53-mediated apoptosis and DNA repair. Mol Pharmacol, 10(5) : 966-72.
Jung MS,Jin DH,Chae HD,Kang S,Kim SC,Bang YJ .2004 .Bcl-xL and E1B-19K proteins inhibit p53-induced irreversible growth arrest and senescence by preventing reactive oxygen species-dependent p38 activation. J Biol Chem, 10(17) : 17765-71.
Levine AJ .1997 .the cellular gatekeeper for growth and division. Cell, 8674(00) : 81871-1.
Vaddavalli PL,Schumacher B. .2022 .The p53 network: Cellular and systemic DNA damage responses in cancer and aging. Trends Genet, 02(6) : 598-612.
Rodier F,Campisi J,Bhaumik D .2007 .Two faces of p53: aging and tumour suppression. Nucleic Acids Res, 10(22) : 7475-84.
Lu D,Faizi M,Drown B,Simerzin A,Francois J,Bradshaw G .2024 .Temporal regulation of gene expression through integration of p53 dynamics and modi cationsS. ci Adv, 10(43) : .
Sturmlechner I,Zhang C,Sine CC,van Deursen EJ,Jeganathan KB,Hamada N .2021 .p21 produces a bioactive secretome that places stressed cells under immunosurveillance. Science, 10(6567) : .
Ito A,Lai CH,Zhao X,Saito S,Hamilton MH,Appella E .2001 .p300/CBP-mediated p53 acetylation is commonly induced by p53-activating agents and inhibited by MDM2. EMBO J, 10(6) : 1331-40.
Sakaguchi K,Herrera JE,Saito S,Miki T,Bustin M,Vassilev A .1998 .DNA damage activates p53 through a phosphorylation-acetylation cascade. Genes Dev, 10(18) : 2831-41.
Solomon JM,Pasupuleti R,Xu L,McDonagh T,Curtis R,DiStefano PS .2006 .Inhibition of SIRT1 catalytic activity increases p53 acetylation but does not alter cell survival following DNA damage. / MCB.26.1, 10(1) : 28-38.
Tang Y,Ju W,Liu Y,Deng Q. .2024 .The role of SIRT1 in autophagy and drug resistance: Unveiling new targets and potential biomarkers in cancer therapy. Front Pharmacol, 1469830 : 1469830.
Dong W,Zhang K,Wang X,Li J,Zou H,Yuan Y .2024 .SIRT1 alleviates Cd nephrotoxicity through NF-kappaB/p65 deacetylation-mediated pyroptosis in rat renal tubular epithelial cells. Sci Total Environ, 172392 : 172392.